ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.18M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−639.00
Price / share
$542.76
Trade value
$346.82K
% of position
Common Stock
Shares
−2.34K
Price / share
$543.48
Trade value
$1.27M
% of position
Common Stock
Shares
−1.49K
Price / share
$544.56
Trade value
$812.48K
% of position
Common Stock
Shares
−1.51K
Price / share
$545.52
Trade value
$822.10K
% of position
Common Stock
Shares
−1.45K
Price / share
$546.46
Trade value
$793.46K
% of position
Common Stock
Shares
−630.00
Price / share
$547.47
Trade value
$344.91K
% of position
Common Stock
Shares
−698.00
Price / share
$548.49
Trade value
$382.84K
% of position
Common Stock
Shares
−502.00
Price / share
$549.47
Trade value
$275.83K
% of position
Common Stock
Shares
−160.00
Price / share
$550.59
Trade value
$88.09K
% of position
Common Stock
Shares
−80.00
Price / share
$551.49
Trade value
$44.12K
% of position
Net shares
+0.00
Net value
-$4.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/13/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −639.00 | $542.76 | $346.82K | 0.2% | 333.94K | 333.30K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −2.34K | $543.48 | $1.27M | 0.7% | 333.30K | 330.96K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −1.49K | $544.56 | $812.48K | 0.5% | 330.96K | 329.47K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −1.51K | $545.52 | $822.10K | 0.5% | 329.47K | 327.96K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −1.45K | $546.46 | $793.46K | 0.4% | 327.96K | 326.51K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −630.00 | $547.47 | $344.91K | 0.2% | 326.51K | 325.88K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −698.00 | $548.49 | $382.84K | 0.2% | 325.88K | 325.19K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −502.00 | $549.47 | $275.83K | 0.2% | 325.19K | 324.68K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −160.00 | $550.59 | $88.09K | 0.0% | 324.68K | 324.52K |
| Common Stock Indirect | 10/13/2026 | S · Sale | −80.00 | $551.49 | $44.12K | 0.0% | 324.52K | 324.44K |
| Total | +0.00 | -$4.06M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
242.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 10/13/2026 | M · Option Exercise | −9.50K | 117.76 | — | 242.91K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
DirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 166.00 | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 40.51K | Direct |
| Common Stock | 45.60K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |